Advertisement Marshall Edwards announces resignation of board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Marshall Edwards announces resignation of board member

Marshall Edwards, an oncology company, has announced that Stephen Breckenridge resigned as a member of the board of directors for personal reasons.

Mr Breckenridge was the chairman of the audit committee and served as the audit committee financial expert. He also served as a member of the compensation committee.

The board has appointed William Rueckert, an existing member of the board, as chairman of the audit committee.

As a result of Mr Breckenridge’s resignation, the size of the board of directors has decreased from six to five members.